SNB-19 Cells

Name: CLS Cell Lines Service GmbH
Address: Dr.-Eckener-Straße 8, Eppelheim, 69214, DE
Telephone: +496221405780
Price range: €€€

545,10 CAD$*

Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 10⁶ cells for adherent lines or 5 × 10⁶ cells for suspension lines (refer to the batch CoA for details).

Prix hors taxes, frais de livraison en sus

cryovial

Numéro de produit : 305492

Fiche signalétique

Fiche de produit

Certificat d'analyse (CoA)

Description	The SNB-19 cell line is a human glioblastoma multiforme (GBM) model derived from a high-grade glioma tumor. It is one of the widely studied glioma cell lines and is used for exploring the biology of aggressive brain tumors, especially glioblastoma. SNB-19 cells exhibit epithelial morphology and are adherent in culture. They have been extensively used in studies of tumor proliferation, invasion, and response to therapy, particularly for investigating glioblastoma's resistance mechanisms to conventional treatments. Genomic profiling of SNB-19 cells has revealed important genetic alterations commonly associated with GBM, including mutations in tumor suppressor genes and oncogenes such as TP53, EGFR, and PTEN. These cells also demonstrate chromosomal abnormalities, including amplification of oncogenic drivers and deletions in tumor suppressor loci. The genetic landscape of SNB-19 provides an important model for studying the molecular pathways driving GBM pathogenesis and for identifying potential targets for therapy. SNB-19 has been used extensively to evaluate the efficacy of novel chemotherapeutics and targeted agents. The cell line is also employed in assays studying glioblastoma's invasive and migratory properties, as it effectively mimics the highly invasive nature of GBM in vitro. Moreover, proteomic analyses of SNB-19 have contributed to understanding protein-level dysregulations and their correlation with genetic alterations in glioblastoma. These characteristics make SNB-19 an essential tool in translational research focused on glioblastoma.
Organisme	Human
Tissu	Brain, parietal lobe
Maladie	Astrocytoma
Synonymes	SNB.19, SNB19, Surgical Neurology Branch-19

Âge	75 years
Genre	Male
Origine ethnique	Caucasian
Morphologie	Fibroblast-like
Type de cellule	Fibroblast
Propriétés de croissance	Adherent, monolayer

Référence	SNB-19 (Cytion catalog number 305492)
Niveau de biosécurité	1
NCBI_Numéro d'identification fiscale	9606
Cellosaurus - Numéro d'enregistrement	CVCL_0535

Profil mutationnel	Mutation: PTEN, Simple, p.Glu242Valfs*15 (c.723_724dupTG), Homozygous; Mutation: TERT, Simple, c.1-124C>T (c.228C>T) (C228T), Unspecified; Mutation: TP53, Simple, p.Arg273His (c.818G>A), Homozygous

Milieu de culture	DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 3.7 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
Suppléments	Supplement the medium with 10% FBS
Temps de doublement	24 hours
Densité de semis	1-4 x 10⁴ cells/cm2
Renouvellement des fluides	2 to 3 times per week
Milieu de congélation	As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress.
Décongélation et culture des cellules	Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently. Centrifuge the mixture at 300 x g for 3 minutes to separate the cells and carefully discard the supernatant containing residual freezing medium. Gently resuspend the cell pellet in 10 ml of fresh culture medium. For adherent cells, divide the suspension between two T25 culture flasks; for suspension cultures, transfer all the medium into one T25 flask to promote effective cell interaction and growth. Adhere to established subculture protocols for continued growth and maintenance of the cell line, ensuring reliable experimental outcomes.
Atmosphère d'incubation	37°C, 5% CO₂, humidified atmosphere.
Conditions d'expédition	Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.
Conditions d'entreposage	For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.

Stérilité	Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections.

Numéro de lot	Type de certificat	Date	Numéro de catalogue
305492-170325	Certificat d'analyse	23. May. 2025	305492
305492-190126	Certificat d'analyse	02. Mar. 2026	305492

SNB-19 Cells

Renseignements généraux

Caractéristiques

Données réglementaires

Données biomoléculaires

Manipulation

Contrôle de la qualité et analyse moléculaire

Certificat d'analyse (CoA)